Go back to News
NEWS
Íñigo Igartua foresees an increase in demand for Competition teams | El Confidencial
The fight against AI-engineered fraud and anti-competitive behaviour has led to the application of more Competition rules and regulation.
The increase in demand on the Competition teams responds to a clear trend: both the authorities and regulatory production have intensified controls. ‘Instruments have multiplied: merger control, foreign investment control and control of third country subsidies. There are more and more ‘controls’ to be considered in the timing of an operation. In addition, the CNMC is more interventionist than ever: it demanded remedies or opened a second phase in 14% of operations in 2024, and has already opened two second phases in 2025,’ explains Íñigo Igartua.
Press contact

Sandra Cuesta
Director of Business Development, Marketing and Communications

Sandra Cuesta
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
PUBLICATION
10 Mar, 2025
Pharma & Healthcare No. 42
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
15 Jan, 2025
New Supreme Court doctrine on the nullity of fuel supply arrangements on grounds of competition law infringements
Analysis of the Supreme Court judgments of 6 and 7 November 2024 establishing a new doctrine on the fixing of retail fuel prices at service stations and on the binding effect of national competition authorities’ decisions on national judges and courts.
PUBLICATION
13 Dec, 2024
Invalidity of franchise providing for franchisor price-setting: implications in terms of restitution
The age-old problem of whether Article 1303 or 1306 of the Civil Code applies to contracts in breach of competition law.
PUBLICATION
26 Nov, 2024
Pharma & Healthcare No. 41
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
21 Nov, 2024
Farma & Salud N.º 41
Se recogen las principales novedades legislativas y jurisprudenciales en el sector de Farma & Salud.